A Yeast‐Based Assay for Inhibitors of <scp>l</scp>‐Lactate Transport Utilizing Fluorescent Biosensors
Inhibitors of ʟ-lactate transport are in development as a novel mode of action in antitumor therapy and malaria. Previously, we used radiolabeled ʟ-lactate to assay transport via the human monocarboxylate transporter 1, MCT1, and the structurally unrelated malaria parasite's transporter, PfFNT. We encountered a sensitivity limit at IC<sub>50</sub> around 100 nM possibly resulting from the required high cell number per sample. Here, we describe a sensitive background-free high-throughput assay in yeast based on fluorescent iLACCO biosensors. We used iLACCO for co-expression and fusions with the transporter protein. Uptake of ʟ-lactate produced strong intensiometric fluorescent responses that could be monitored in cell suspensions using a fluorometer and in individual cells by fluorescence microscopy. The signal decreased dose-dependently in the presence of specific MCT1 and PfFNT inhibitors. Re-evaluation of 36 PfFNT inhibitors yielded IC<sub>50</sub> values below 100 nM now matching previous data on K<sub>i</sub> compound affinity to isolated transporter protein.
Authors
- Eric Beitz (ORCID: https://orcid.org/0000-0001-5912-6626)
- Manfred Menzel
- Finn Tiedjens
- Pauline Stahnke
- Hanna Grotewold
- Cane Uzun
- Derya Yildirim
Institutions
- Christian-Albrechts-Universität zu Kiel (DE)
Publication Details
- Journal
- ChemMedChem
- Published
- 2024-12-13
- DOI
- https://doi.org/10.1002/cmdc.202400918
- Citations
- 1
- Primary Topic
- Drug Transport and Resistance Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- Deutsche Forschungsgemeinschaft